Home > Healthcare > Biotechnology > Biotechnology R&D > Cell Isolation Market

Cell Isolation Market Share

Report ID: GMI6469
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Cell Isolation Market Share

The prominent players in the cell isolation market are:

Thermo Fisher Scientific, Inc.
Danaher Corporation,
Merk KGaA
Becton Dickinson & Company
Agilent Technologies Inc.
Terumo Corporation
Bio-Rad Laboratories Inc.
F. Hoffmann-La Roche Ltd,
Corning Inc.
STEMCELL Technologies Inc.
Invent Biotechnologies
Qiagen NV,
Alfa Laval AB
Sartorius AG
Bio-Techne Corporation.

These companies are implementing several strategies such as collaborations, acquisitions, partnerships, mergers, and product launches to maintain a competitive edge in the industry.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market for cell isolation size was valued to be USD 5.2 billion in 2022 and is expected to reach over USD 16 billion by 2032, driven by the rising prevalence of chronic and infectious diseases such as cancer and COVID-19, government support for cell-based research, and growing emphasis on customized therapy.

Due to increasing incidence of chronic and infectious diseases such as cancer, the human cells segment held the largest market share in 2022 and is expected to grow at CAGR of 12.2% during 2023 to 2032.

North American cell isolation market accounted for revenue share of 42.8% in 2022 and will continue to grow through 2032, due to a considerable increase in patient pool of chronic diseases, and government funding for cancer R&D in pharmaceutical & biotechnological sector.

Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Corning Inc., STEMCELL Technologies Inc., Invent Biotechnologies, Qiagen NV, Alfa Laval AB, Sartorius AG, and Bio-Techne Corporation.